2025 first_quarter Filing
Q1Filed
April 21, 2025
Lobbying Activities
Medical/Disease Research/Clinical LabsView all
Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions
Contacted:Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PharmacyView all
Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions
Contacted:Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (2)
mr MICHAEL P STRAZZELLA
SOPHIA ESTUPINAN